Radiopharmaceuticals and their applications in medicine
Open accessThe DOI matches its Crossref record; 454 of the 454 references it cites were found in a registry or an index.
Abstract
Radiopharmaceuticals involve the local delivery of radionuclides to targeted lesions for the diagnosis and treatment of multiple diseases. Radiopharmaceutical therapy, which directly causes systematic and irreparable damage to targeted cells, has attracted increasing attention in the treatment of refractory diseases that are not sensitive to current therapies. As the Food and Drug Administration (FDA) approvals of [177 Lu]Lu-DOTA-TATE, [177 Lu]Lu-PSMA-617 and their complementary diagnostic agents, namely, [68 Ga]Ga-DOTA-TATE and [68 Ga]Ga-PSMA-11, targeted radiopharmaceutical-based theranostics (radiotheranostics) are being increasingly implemented in clinical practice in oncology, which lead to a new era of radiopharmaceuticals. The new generation of radiopharmaceuticals utilizes a targeting vector to achieve the accurate delivery of radionuclides to lesions and avoid off-target deposition, making it possible to improve the efficiency and biosafety of tumour diagnosis and therapy. Numerous studies have focused on developing novel radiopharmaceuticals targeting a broader range of disease targets, demonstrating remarkable in vivo performance. These include high tumor uptake, prolonged retention time, and favorable pharmacokinetic properties that align with clinical standards. While radiotheranostics have been widely applied in tumor diagnosis and therapy, their applications are now expanding to neurodegenerative diseases, cardiovascular diseases, and inflammation. Furthermore, radiotheranostic-empowered precision medicine is revolutionizing the cancer treatment paradigm. Diagnostic radiopharmaceuticals play a pivotal role in patient stratification and treatment planning, leading to improved therapeutic outcomes in targeted radionuclide therapy. This review offers a comprehensive overview of the evolution of radiopharmaceuticals, including both FDA-approved and clinically investigated agents, and explores the mechanisms of cell death induced by radiopharmaceuticals. It emphasizes the significance and future prospects of theranostic-based radiopharmaceuticals in advancing precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 454
First-in-human uPAR PET: Imaging of Cancer Aggressiveness
Persson, M., Skovgaard, D., Brandt-Larsen, M., Christensen, C., Madsen, J., Nielsen, C. H., Thurison, T., Klausen, T. L., Holm, S., Loft, A., et al. (2015) · Theranostics · doi:10.7150/thno.12956 · Cited by 114
Hamano, T., Enomoto, S., Shirafuji, N., Ikawa, M., Yamamura, O., Yen, S.-H., & Nakamoto, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147475 · Cited by 114
Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy
Wu, Z., Martinez-Fong, D., Trédaniel, J., & Forgez, P. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00184 · Cited by 113
Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer
Mudd, G., Scott, H. S., Chen, L., Rietschoten, K. V., Ivanova-Berndt, G., Dzionek, K., Brown, A. N., Watcham, S. M., White, L., Park, P. U., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00065 · Cited by 113
Reidy-Lagunes, D., Pandit-Taskar, N., O'Donoghue, J. A., Krebs, S., Staton, K. D., Lyashchenko, S. K., Lewis, J. S., Raj, N., Gönen, M., Lohrmann, C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1026 · Cited by 112
Natarajan, A., Mayer, A. T., Reeves, R. E., Nagamine, C. M., & Gambhir, S. S. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1060-3 · Cited by 111
Best Practices for Imaging Cardiac Device–Related Infections and Endocarditis
Dilsizian, V., Budde, R. P. J., Chen, W., Mankad, S. V., Lindner, J. R., & Nieman, K. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2021.09.029 · Cited by 111
Intracellular Self-Assembly of Peptides to Induce Apoptosis against Drug-Resistant Melanoma
Sun, M., Wang, C., Lv, M., Fan, Z., & Du, J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c00697 · Cited by 109
Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma
Grillo-López, A. J. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.5.485 · Cited by 108
Hausner, S. H., Bold, R. J., Cheuy, L. Y., Chew, H. K., Daly, M. E., Davis, R. A., Foster, C. C., Kim, E. J.-H., & Sutcliffe-Goulden, J. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2665 · Cited by 107
IDO/kynurenine pathway in cancer: possible therapeutic approaches
El-Fattah, E. E. A. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03554-w · Cited by 107
Using PSMA imaging for prognostication in localized and advanced prostate cancer
Roberts, M. J., Maurer, T., Perera, M., Eiber, M. J., Hope, T. A., Ost, P., Siva, S., Hofman, M. S., Murphy, D. G., Emmett, L., et al. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00670-6 · Cited by 106
Baum, R. P., Singh, A., Schuchardt, C., Kulkarni, H., Klette, I., Wiessalla, S., Osterkamp, F., Reineke, U., & Smerling, C. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.193847 · Cited by 105
Duan, X., Xia, L., Zhang, Z., Ren, Y., Pomper, M. G., Rowe, S. P., Li, X., Li, N., Zhang, N., Zhu, H., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0609 · Cited by 105
Imaging of Synaptic Density in Neurodegenerative Disorders
Carson, R. E., Naganawa, M., Toyonaga, T., Koohsari, S., Yang, Y., Chen, M.-K., Matuskey, D., & Finnema, S. J. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263201 · Cited by 104
Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET
Rodriguez-Porcel, M. G., Cai, W., Gheysens, O. S., Willmann, J. K., Chen, K., Wang, H., Chen, I. Y., He, L., Wu, J. C., Li, Z., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.040576 · Cited by 103
Self-citationAntitumor Immunity Induced after α Irradiation
Gorin, J.-B., Ménager, J., Gouard, S., Maurel, C., Guilloux, Y., Faivre-Chauvet, A., Morgenstern, A., Bruchertseifer, F., Chérel, M., Davodeau, F., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.04.002 · Cited by 103
Terry, G. E., Hirvonen, J., Liow, J.-S., Zoghbi, S. S., Gladding, R., Tauscher, J. T., Schaus, J. M., Phebus, L., Felder, C. C., Morse, C. L., et al. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.067074 · Cited by 101
In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with18F-PBR111 PET
Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.135129 · Cited by 100
In vivo albumin labeling and lymphatic imaging
Wang, Y., Lang, L., Huang, P., Wang, Z., Jacobson, O., Kiesewetter, D. O., Ali, I. U., Teng, G., Niu, G., & Chen, X. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414821112 · Cited by 100
Self-citationKok, I. C., Hooiveld-Noeken, J. S., van de Donk, P. P., Giesen, D., van der Veen, E. L., Hooge, M. N. L., Brouwers, A. H., Hiltermann, T. J. N., van der Wekken, A. J., Hijmering-Kappelle, L. B. M., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.10.213 · Cited by 100
Prostate-specific Membrane Antigen PET in Prostate Cancer
Lawhn-Heath, C. A., Salavati, A., Behr, S. C., Rowe, S. P., Calais, J., Fendler, W. P., Eiber, M., Emmett, L., Hofman, M. S., & Hope, T. A. (2021) · Radiology · doi:10.1148/radiol.2021202771 · Cited by 99
Cell spheroid creation by transcytotic intercellular gelation
Guo, J., Wang, F., Huang, Y., He, H., Tan, W., Yi, M., Egelman, E. H., & Xu, B. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01401-7 · Cited by 99
Visualization of AMPA receptors in living human brain with positron emission tomography
Miyazaki, T., Nakajima, W., Hatano, M., Shibata, Y., Kuroki, Y., Arisawa, T., Serizawa, A., Sano, A., Kogami, S., Yamanoue, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0723-9 · Cited by 97
Hampton, J. T., & Liu, W. R. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00004 · Cited by 97
Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy
Zhang, P., Xu, M., Ding, J., Chen, J., Zhang, T., Huo, L., & Liu, Z. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05591-x · Cited by 96
Quigley, N. G., Steiger, K., Hoberück, S., Czech, N., Zierke, M. A., Kossatz, S., Pretze, M., Richter, F., Weichert, W., Pox, C. P., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05559-x · Cited by 94
Synaptic Loss in Primary Tauopathies Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Holland, N., Jones, P. S., Savulich, G., Wiggins, J. K., Hong, Y. T., Fryer, T. D., Manavaki, R., Sephton, S. M., Boros, I., Malpetti, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28188 · Cited by 93
A Model of Cell Inactivation by Alpha-Particle Internal Emitters
Humm, J. L., & Chin, L. M. (1993) · Radiation Research · doi:10.2307/3578453 · Cited by 93
OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
Deng, J., Zhao, S., Zhang, X., Jia, K., Wang, H., Zhou, C., & He, Y. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s214211 · Cited by 93
Cardiovascular Imaging in Infective Endocarditis: A Multimodality Approach
Horgan, S. J., Mediratta, A., & Gillam, L. D. (2020) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.008956 · Cited by 93
Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation
Queen, A., Bhutto, H. N., Yousuf, M., Syed, M. A., & Hassan, M. I. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.001 · Cited by 93
GPC3-targeted immunoPET imaging of hepatocellular carcinomas
An, S., Zhang, D., Zhang, Y., Wang, C., Shi, L., Wei, W., Huang, G., & Liu, J. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05723-x · Cited by 93
Current Consensus on I-131 MIBG Therapy
Kayano, D., & Kinuya, S. (2018) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-018-0523-z · Cited by 92
Nicolas, G. P., Beykan, S., Bouterfa, H., Kaufmann, J., Bauman, A., Lassmann, M., Reubi, J. C., Rivier, J. E. F., Maecke, H. R., Fani, M., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199737 · Cited by 91
Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
Kramer, K., Pandit-Taskar, N. D., Kushner, B. H., ZANZONICO, P. B., Humm, J. L., Tomlinson, U., Donzelli, M. A., Wolden, S. L., Haque, S., Dunkel, I. J., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01383-4 · Cited by 90
Sharma, S., Verma, S., Kapoor, M., Saini, A., & Nehru, B. (2016) · Neurological Research · doi:10.1080/01616412.2016.1209337 · Cited by 89
Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
Simonetta, F., Alam, I. S., Lohmeyer, J. K., Sahaf, B., Good, Z., Chen, W., Xiao, Z., Hirai, T., Scheller, L., Engels, P., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2770 · Cited by 89
In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment
Vanhaute, H., Ceccarini, J., Michiels, L., Koole, M., Sunaert, S., Lemmens, R., Triau, E., Emsell, L., Vandenbulcke, M., & Van Laere, K. (2020) · Neurology · doi:10.1212/wnl.0000000000009818 · Cited by 88
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer Treatment
Kleinendorst, S. C., Oosterwijk, E., Bussink, J., Westdorp, H., Konijnenberg, M., & Heskamp, S. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4332 · Cited by 87
Multiplexed imaging in cancer diagnosis: applications and future advances
Kobayashi, H., Longmire, M. R., Ogawa, M., Choyke, P. L., & Kawamoto, S. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70009-7 · Cited by 86
Unterrainer, M., Mahler, C. F., Vomacka, L., Lindner, S., Havla, J. B., Brendel, M., Böning, G., Ertl-Wagner, B. B., Kümpfel, T., Milenkovic, V. M., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3974-7 · Cited by 84
Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ 11 C ] UCB‐J PET Imaging Study
Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjærbæk, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J., et al. (2021) · Movement Disorders · doi:10.1002/mds.28617 · Cited by 84
Skovgaard, D. C., Persson, M., Brandt-Larsen, M., Christensen, C. L., Madsen, J., Klausen, T. L., Holm, S., Andersen, F. L., Loft, A., Berthelsen, A. K., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178970 · Cited by 82
Intra-Lysosomal Peptide Assembly for the High Selectivity Index against Cancer
Jana, B., Jin, S., Go, E. M., Cho, Y., Kim, D., Kim, S., Kwak, S. K., & Ryu, J. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04467 · Cited by 82
Kung, M., Hou, C., Goswami, R., Ponde, D. E., Kilbourn, M. R., & Kung, H. F. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.12.005 · Cited by 81
Ahmad, R. U., Koole, M. J. B., Evens, N., Serdons, K., Verbruggen, A., Bormans, G. M., & Laere, K. V. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0626-y · Cited by 80
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
Evens, N., Vandeputte, C., Coolen, C., Janssen, P., Sciot, R., Baekelandt, V., Verbruggen, A., Debyser, Z., Laere, K. V., & Bormans, G. M. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.09.005 · Cited by 80
Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
Dehdashti, F., Laforest, R., Gao, F., Shoghi, K. I., Aft, R. L., Nussenbaum, B., Kreisel, F. H., Bartlett, N. L., Cashen, A., Wagner-Johnson, N., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.111948 · Cited by 80
Constantinescu, C. C., Tresse, C., Zheng, M., Gouasmat, A., Carroll, V. M., Mistico, L., Alagille, D., Sandiego, C. M., Papin, C., MAREK, K. L., et al. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1260-5 · Cited by 80
Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study
Chen, M.-K., Mecca, A. P., Naganawa, M., Gallezot, J.-D., Toyonaga, T., Mondal, J., Finnema, S. J., Lin, S.-F., O’Dell, R. S., McDonald, J. W., et al. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211004312 · Cited by 79
Yadav, M. P., Ballal, S., Martin, M., Roesch, F., Satapathy, S., Moon, E. S., Tripathi, M., Gogia, A., & Bal, C. S. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06482-z · Cited by 79
Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies
Juhász, C., Nahleh, Z. A., Zitron, I. M., Chugani, D. C., Janabi, M., Bandyopadhyay, S., Ali‐Fehmi, R., Mangner, T. J., Chakraborty, P. K., Mittal, S., et al. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.01.010 · Cited by 78
Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
Rondon, A., Rouanet, J., & Degoul, F. (2021) · Cancers · doi:10.3390/cancers13215570 · Cited by 78
Öberg, K. (2012) · Theranostics · doi:10.7150/thno.3931 · Cited by 77
Research Progress of Indoleamine 2,3-Dioxygenase Inhibitors
Jiang, T., Sun, Y., Yin, Z., Feng, S., Sun, L., & Li, Z. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.151 · Cited by 77
Li, L., Wu, Y., Wang, Z., Jia, B., Hu, Z., Dong, C., & Wang, F. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183863 · Cited by 77
Self-citationHuisman, M. C., Niemeijer, A.-L. N., Windhorst, A. D., Schuit, R. C., Leung, D. K.-W., Hayes, W., Poot, A. J., Bahce, I., Radonic, T., Oprea‐Lager, D. E., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.240895 · Cited by 77
Mueller, R. L., Combs, B., Alhadidy, M. M., Brady, S. T., Morfini, G. A., & Kanaan, N. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.647054 · Cited by 76
Development of [ 18 F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
Lesniak, W. G., Mease, R. C., Chatterjee, S., Kumar, D., Lisok, A., Wharram, B. L., Kalagadda, V. R., Emens, L. A., Pomper, M. G., & Nimmagadda, S. (2019) · Molecular Imaging · doi:10.1177/1536012119852189 · Cited by 75
Li, J., Xing, J., Yang, Y., Liu, J., Wang, W., Xia, Y., Yan, Z., Wang, K., Wu, D., Wu, L. Y., et al. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30422-4 · Cited by 75
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
Bolcaen, J., Kleynhans, J., Nair, S., Verhoeven, J., Goethals, I., Sathekge, M. M., Vandevoorde, C., & Ebenhan, T. (2021) · Theranostics · doi:10.7150/thno.56639 · Cited by 75
Zürcher, N. R., Loggia, M. L., Mullett, J. E., Tseng, C.-E. J., Bhanot, A., Richey, L., Hightower, B. G., Wu, C. J., Parmar, A. J., Butterfield, R. I., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0682-z · Cited by 74
Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis
Freise, A. C., Zettlitz, K. A., Salazar, F. B., Tavaré, R., Tsai, W.-T. K., Chatziioannou, A. F., Rozengurt, N., Braun, J., & Wu, A. M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199075 · Cited by 72
DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
Monfared, Y. K., Heidari, P., Klempner, S. J., Mahmood, U., Parikh, A. R., Hong, T. S., Strickland, M. R., & Esfahani, S. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122761 · Cited by 72
Henriksen, G., Yousefi, B. H., Drzezga, A. E., & Wester, H. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0705-x · Cited by 71
Schuelert, N., Johnson, M. P., Oskins, J. L., Jassal, K., Chambers, M. G., & McDougall, J. J. (2011) · Pain · doi:10.1016/j.pain.2010.11.025 · Cited by 70
Wideł, M., Przybyszewski, W. M., Cieślar‐Pobuda, A., Saenko, Y., & Rzeszowska‐Wolny, J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.12.007 · Cited by 69
ImmunoPET imaging of multiple myeloma with [68Ga]Ga-NOTA-Nb1053
Wang, C., Chen, Y., Hou, Y. N., Liu, Q., Zhang, D., Zhao, H., Zhang, Y., An, S., Li, L., Hou, J., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05218-1 · Cited by 69
Self-citationInternational consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
Tian, M., Civelek, A. C., Carrió, I., Watanabe, Y., Kang, K. W., Murakami, K., Garibotto, V., Prior, J. O., Barthel, H., Zhou, R., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05673-w · Cited by 69
In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET
Zhao, N., Bardine, C., Lourenço, A. L., Wang, Y.-H., Huang, Y., Cleary, S. J., Wilson, D. M., Oh, D. Y., Fong, L. H., Looney, M. R., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00529 · Cited by 68
Hou, L., Rong, J., Haider, A., Ogasawara, D., Varlow, C., Schafroth, M. A., Mu, L., Gan, J., Xu, H., Fowler, C. J., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01459 · Cited by 67
Fayn, S., King, A., Gutsche, N. T., Duan, Z., Buffington, J., Olkowski, C. P., Fu, Y., Hong, J., Sail, D., Baidoo, K. E., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.265171 · Cited by 67
Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
Lin, F., Clift, R., Ehara, T., Yanagida, H., Horton, S., Noncovich, A., Guest, M., Kim, D., Salvador, K., Richardson, S., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266766 · Cited by 67
Self-citationThe in Vitro Radiobiology of Astatine-211 Decay
Kassis, A. I., Harris, C. R., & Adelstein, S. J. (1986) · Radiation Research · doi:10.2307/3576722 · Cited by 66
Meng, L., Fang, J., Zhao, L., Wang, T., Yuan, P., Zhao, Z., Zhuang, R., Lin, Q., Chen, H., Chen, X. S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02162 · Cited by 64
Self-citationUptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques
Laitinen, I., Marjamäki, P., Någren, K., Laine, V. J. O., Wilson, I., Leppänen, P., Ylä‐Herttuala, S., Roivainen, A., & Knuuti, J. M. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0919-6 · Cited by 62
Fu, H., Chen, Z., Josephson, L., Li, Z., & Liang, S. H. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00714 · Cited by 62
Zia, N. A., Cullinane, C. M., Zuylekom, J. V., Waldeck, K., McInnes, L. E., Buncic, G., Haskali, M. B., Roselt, P. D., Hicks, R. J., & Donnelly, P. S. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908964 · Cited by 62
Li, S., Naganawa, M., Pracitto, R., Najafzadeh, S., Holden, D., Henry, S., Matuskey, D., Emery, P. R., Cai, Z., Ropchan, J., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05149-3 · Cited by 61
Zhang, Y., Hong, H., Engle, J. W., Yang, Y., Barnhart, T. E., & Cai, W. (2012) · PubMed · Cited by 61
PET/CT imaging of renal cell carcinoma with 18F-VM4-037: a phase II pilot study
Türkbey, B., Lindenberg, M. L., Adler, S., Kurdziel, K., McKinney, Y. L., Weaver, J., Vocke, C. D., Anver, M. R., Bratslavsky, G., Eclarinal, P. C., et al. (2015) · Abdominal Radiology · doi:10.1007/s00261-015-0599-1 · Cited by 61
Wang, L., Mori, W., Cheng, R., Yui, J., Hatori, A., Ma, L., Zhang, Y., Rotstein, B. H., Fujinaga, M., Shimoda, Y., et al. (2016) · Theranostics · doi:10.7150/thno.15257 · Cited by 61
O’Steen, S., Comstock, M., Orozco, J. J., Hamlin, D. K., Wilbur, D. S., Jones, J. C., Kenoyer, A. L., Nartea, M. E., Lin, Y., Miller, B. W., et al. (2019) · Blood · doi:10.1182/blood.2019001250 · Cited by 61
Mecca, A. P., Chen, M.-K., O'Dell, R. S., Naganawa, M., Toyonaga, T., Godek, T. A., Harris, J. E., Bartlett, H. H., Zhao, W., Banks, E. R., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.11.004 · Cited by 61
Schulz, J., Rohracker, M., Stiebler, M., Goldschmidt, J., Stöber, F., Noriega, M., Pethe, A., Lukas, M., Osterkamp, F., Reineke, U., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.185140 · Cited by 60
Sgouros, G. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2019.11.002 · Cited by 60
Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE Therapy
O’Neill, E. S., Kersemans, V., Allen, P. D., Terry, S. Y. A., Torres, J. B., Mosley, M. J., Smart, S., Lee, B. Q., Falzone, N., Vallis, K. A., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.232934 · Cited by 59
Best, L. M., Williams, B., Foll, B. L., Mansouri, E., Bazinet, R. P., Lin, L., Luca, V. D., Lagzdins, D., Rusjan, P., Tyndale, R. F., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0606-2 · Cited by 59
The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
Werner, R. A., Thackeray, J. T., Diekmann, J., Weiberg, D., Bauersachs, J. K., & Bengel, F. M. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.240440 · Cited by 59
Metabotropic glutamate receptors: new targets for the control of tumor growth?
Nicoletti, F., Arcella, A., Iacovelli, L., Battaglia, G., Giangaspero, F., & Melchiorri, D. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.008 · Cited by 56
Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors
Li, L., Chen, X. S., Yu, J., & Yuan, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.837952 · Cited by 56
Self-citation68Ga-FAPI PET visualize heart failure: from mechanism to clinic
Song, W., Zhang, X., He, S., Gai, Y., Qin, C., Hu, F., Wang, Y., Wang, Z., Bai, P., Wang, J., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05994-4 · Cited by 56
Olivier, P., Giraudet, A., Skanjeti, A., Merlin, C., Weinmann, P., Rudolph, I., Hoepping, A., & Gauthé, M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264743 · Cited by 56
Yousefi, B. H., Drzezga, A. E., von Reutern, B., Manook, A., Schwaiger, M., Wester, H., & Henriksen, G. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200123w · Cited by 55
Natarajan, A., Patel, C. B., Habte, F. G., & Gambhir, S. S. (2018) · Scientific Reports · doi:10.1038/s41598-017-19123-x · Cited by 55
Hu, K., Hanyu, M., Xie, L., Zhang, Y., Nagatsu, K., Hisashi, S., & Zhang, M. (2019) · Chemical Communications · doi:10.1039/c9cc00445a · Cited by 55
Self-citationQin, X., Guo, X., Liu, T., Li, L., Zhou, N., Ma, X., Meng, X., Liu, J., Zhu, H., Jia, B., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05967-7 · Cited by 55
Self-citationGriessinger, C. M., Olafsen, T., Mascioni, A., Jiang, Z. K., Zamilpa, C., Jia, F., Torgov, M. Y., Romero, J. M., Marchioni, F., Satpayev, D., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3269 · Cited by 54
Postnov, A. A., Schmidt, M. E., Pemberton, D. J., Hoon, J. N. J. M. D., Hecken, A. V., van den Boer, M., Zannikos, P., van der Ark, P. D., Palmer, J. A., Rassnick, S., et al. (2018) · Clinical and Translational Science · doi:10.1111/cts.12548 · Cited by 53
Kulterer, O. C., Pfaff, S., Wadsak, W., Garstka, N., Mesut Remzi, A., Vraka, C., Nics, L., Mitterhauser, M., Bootz, F., Cazzamalli, S., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.245530 · Cited by 53
Disulfide-Directed Multicyclic Peptide Libraries for the Discovery of Peptide Ligands and Drugs
Lu, S., Fan, S., Xiao, S., Li, J., Zhang, S., Wu, Y., Kong, C., Zhuang, J., Liu, H., Zhao, Y., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c12462 · Cited by 53
Self-citation18F-Fluorobenzoate–Labeled Cystine Knot Peptides for PET Imaging of Integrin αvβ6
Hackel, B. J., Kimura, R. H., Miao, Z., Liu, H., Sathirachinda, A., Cheng, Z., Chin, F. T., & Gambhir, S. S. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.110759 · Cited by 52
Krishnan, A. Y., Adhikarla, V., Poku, E. K., Palmer, J. M., Chaudhry, A. A., Biglang-awa, V. E., Bowles, N., Nathwani, N., Rosenzweig, M. A., Sahebi, F., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002603 · Cited by 52
Dreher, N., Hahner, S., Fuß, C. T., Schlötelburg, W., Hartrampf, P. E., Serfling, S. E., Schirbel, A., Samnick, S., Higuchi, T., Weich, A., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06547-z · Cited by 52
Current radiotracers to image neurodegenerative diseases
Tiepolt, S., Patt, M., Aghakhanyan, G., Meyer, P., Hesse, S., Barthel, H., & Sabri, O. (2019) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-019-0070-7 · Cited by 51
Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study
Delva, A., Michiels, L., Koole, M., Van Laere, K., & Vandenberghe, W. (2022) · Neurology · doi:10.1212/wnl.0000000000012969 · Cited by 51
Dosimetry Estimate and Initial Clinical Experience with 90Y-PSMA-617
Rathke, H. G., Flechsig, P., Mier, W., Bronzel, M., Mavriopoulou, E., Hohenfellner, M., Giesel, F. L., Haberkorn, U., & Kratochwil, C. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.218917 · Cited by 50
Maurer, A., Leonov, A., Ryazanov, S., Herfert, K., Kuebler, L., Buss, S., Schmidt, F., Weckbecker, D., Linder, R., Bender, D., et al. (2019) · ChemMedChem · doi:10.1002/cmdc.201900689 · Cited by 50
18F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy
Messerschmidt, K., Barthel, H., Brendel, M., Scherlach, C., Hoffmann, K., Rauchmann, B., Rullmann, M., MAREK, K. L., Villemagne, V. L., Rumpf, J., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262854 · Cited by 50
Zhou, M., Wang, X., Chen, B., Xiang, S., Rao, W., Zhang, Z., Liu, H., Fang, J., Yin, X., Deng, P., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05876-9 · Cited by 50
Self-citationUncovering atherosclerotic cardiovascular disease by PET imaging
Maier, A., Teunissen, A. J. P., Nauta, S. A., Lutgens, E., Fayad, Z. A., & van Leent, M. M. T. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01009-x · Cited by 50
Hu, K., Wu, W., Xie, L., Geng, H. R., Zhang, Y., Hanyu, M., Zhang, L., Liu, Y., Nagatsu, K., Suzuki, H., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.016 · Cited by 49
Self-citationPeng, S., Zhan, Y., Zhang, D., Ren, L., Chen, A., Chen, Z., & Zhang, H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216230120 · Cited by 49
The impact of the rs6971 polymorphism in TSPO for quantification and study design
Owen, D. R., Guo, Q., Rabiner, E. A., & Gunn, R. N. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0141-z · Cited by 47
Wurzer, A. J., Kunert, J.-P., Fischer, S., Felber, V. B., Beck, R., Rose, F. D., D’Alessandria, C., Weber, W., & Wester, H. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263371 · Cited by 47
Chen, Y., Hou, X., Li, D., Ding, J., Liu, J., Wang, Z., Teng, F., Li, H., Zhang, F., Gu, Y., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.02.011 · Cited by 46
Linear Peptide-Based PET Tracers for Imaging PD-L1 in Tumors
Zhang, L., Zhang, S., Jiang, W., Wang, Y., Wu, Y., Sun, X., Wang, X., Shen, J., Xie, L., Zhang, Y., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00382 · Cited by 46
Self-citationNordberg, E., Orlova, A., Friedman, M., Максимилианович, Т. В., Ståhl, S., Nilsson, F., Glimelius, B. L. G., & Carlsson, J. (2008) · Oncology Reports · doi:10.3892/or.19.4.853 · Cited by 45
Wang, X., Zhou, M., Chen, B., Liu, H., Fang, J., Xiang, S., Hu, S., & Zhang, X. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05672-x · Cited by 45
Self-citationPersson, M., Juhl, K., Rasmussen, P., Brandt-Larsen, M., Madsen, J., Ploug, M., & Kjær, A. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500177c · Cited by 44
Xin, Y., & Cai, H. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-016-1024-z · Cited by 44
Greco, R., Demartini, C., Zanaboni, A., Casini, I., Icco, R. D., Reggiani, A. M., Misto, A., Piomelli, D., & Tassorelli, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105157 · Cited by 44
Xie, Q., Liu, T., Ding, J. L., Zhou, N., Meng, X., Zhu, H., Li, N., Yu, J., & Yang, Z. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05249-8 · Cited by 44
Synaptic density in carriers of C9orf72 mutations: a [11C]UCB‐J PET study
Malpetti, M., Holland, N., Jones, P. S., Ye, R., Cope, T. E., Fryer, T. D., Hong, Y. T., Savulich, G., Rittman, T., Passamonti, L., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51407 · Cited by 44
Molecular imaging to support cancer immunotherapy
van de Donk, P. P., Oosting, S. F., Knapen, D. G., van der Wekken, A. J., Brouwers, A. H., Hooge, M. N. L., de Groot, D. J., & de Vries, E. G. E. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004949 · Cited by 44
Zhang, J., Li, F., Yin, Y., Liu, N., Zhu, M., Zhang, H., Liu, W., Yang, M., Qin, S., Fan, X., et al. (2022) · Biomaterials Research · doi:10.1186/s40824-022-00290-6 · Cited by 44
Friedberg, J. W., & Fisher, R. I. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.1.18 · Cited by 43
Hellberg, S., Liljenbäck, H., Eskola, O., Morisson, V., Morrison, M. S., Trigg, W., Saukko, P. J., Ylä‐Herttuala, S., Knuuti, J. M., Saraste, A., et al. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/9186902 · Cited by 43
Nazıroğlu, M., Taner, A. N., Balbay, E., & Çiğ, B. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3439-0 · Cited by 43
Hu, G., Zhu, W., Liu, Y., Wang, Y., Zhang, Z., Zhu, S., Duan, W., Zhou, P., Fu, C., Li, F., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05739-3 · Cited by 43
Xu, W., Cai, J., Tianxing, P., Meng, T., Pang, Y., Sun, L., Wu, H., Zhang, J., Chen, X. S., & Chen, H. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266329 · Cited by 43
Self-citationGibbons, A. S., Brooks, L., Scarr, E., & Dean, B. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.001 · Cited by 41
Characterization of 18F-PM-PBB3 (18F-APN-1607) Uptake in the rTg4510 Mouse Model of Tauopathy
Weng, C.-C., Hsiao, I., Yang, Q.-F., Yao, C.-H., Tai, C., Wu, M., Yen, T., Jang, M., & Lin, K. (2020) · Molecules · doi:10.3390/molecules25071750 · Cited by 41
Kolla, N. J., Boileau, I., Karas, K. H., Watts, J. J., Rusjan, P., Houle, S., & Mizrahi, R. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01144-2 · Cited by 41
Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with89Zr in Human Lymphoma Xenografts
Yoon, J. T., Longtine, M. S., Marquez-Nostra, B. V., & Wahl, R. L. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.203299 · Cited by 40
The prognostic value of [123I]-vascular endothelial growth factor ([123I]-VEGF) in glioma
Rainer, E., Wang, H., Traub‐Weidinger, T., Widhalm, G., Fueger, B. J., Chang, J., Zhu, Z., Marosi, C., Haug, A. R., Hacker, M., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4088-y · Cited by 40
Alteba, S., Zer‐Aviv, T. M., Tenenhaus, A., David, G. B., Adelman, J. W., Hillard, C. J., Doron, R., & Akirav, I. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.08.005 · Cited by 40
Labadie, K. P., Hamlin, D. K., Kenoyer, A. L., Daniel, S. K., Utria, A. F., Ludwig, A. D., Kenerson, H. L., Li, L., Sham, J. G., Chen, D. L., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262562 · Cited by 40
Self-citationTSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas
Quach, S., Holzgreve, A., Kaiser, L., Unterrainer, M., Dekorsy, F. J., Nelwan, D. V., Bartos, L. M., Kirchleitner, S. V., Weller, J., Weidner, L., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-06006-1 · Cited by 40
Adnan, A., & Basu, S. K. (2023) · Diagnostics · doi:10.3390/diagnostics13132154 · Cited by 40
Tau PET Imaging with [18F]PM-PBB3 in Frontotemporal Dementia with MAPT Mutation
Su, Y., Fu, J., Yu, J., Zhao, Q., Guan, Y., Zuo, C., Li, M., Tan, H., & Cheng, X. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200287 · Cited by 39
Feuerecker, B., Chantadisai, M., Allmann, A., Tauber, R., Allmann, J., Steinhelfer, L., Rauscher, I., Wurzer, A. J., Wester, H., Weber, W., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262671 · Cited by 39
Selçuk, N. A., Beydağı, G., Demirci, E., Ocak, M., Çelik, S., Öven, B. B., Toklu, T., Karaaslan, İ. Ş., Akçay, K., Sönmez, Ö., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265546 · Cited by 39
Thomsen, M. B., Jacobsen, J., Lillethorup, T. P., Schacht, A. C., Simonsen, M., Romero-Ramos, M., Brooks, D. J., & Landau, A. M. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20931140 · Cited by 38
Synthesis of 5-[18F]Fluoro-α-methyl Tryptophan: New Trp Based PET Agents
Giglio, B. C., Fei, H., Wang, M., Wang, H., He, L., Feng, H., Wu, Z., Lu, H., & Li, Z. (2017) · Theranostics · doi:10.7150/thno.19371 · Cited by 38
Positron emission tomography imaging in cardiovascular disease
Tarkin, J. M., Ćorović, A., Wall, C., Gopalan, D., & Rudd, J. H. F. (2020) · Heart · doi:10.1136/heartjnl-2019-315183 · Cited by 38
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase
Liu, P., Hamill, T. G., Chioda, M. D., Chobanian, H. R., Fung, S., Guo, Y., Chang, L. L., Bakshi, R. K., Hong, Q., Dellureficio, J., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000996 · Cited by 36
Kim, G., Paeng, J. C., Jung, J. H., Moon, B., Lopalco, A., Denora, N., Lee, B. C., & Kim, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010276 · Cited by 36
PET Imaging of VEGFR with a Novel 64Cu-Labeled Peptide
Hu, K., Shang, J., Xie, L., Hanyu, M., Zhang, Y., Yang, Z., Xu, H., Wang, L., & Zhang, M. (2020) · ACS Omega · doi:10.1021/acsomega.9b03953 · Cited by 36
Self-citationBeauchamp, L. C., Doré, V., Villemagne, V. L., Xu, S., Finkelstein, D. I., Barnham, K. J., & Rowe, C. C. (2023) · Neurology · doi:10.1212/wnl.0000000000207748 · Cited by 36
Lin, K., Weng, Y.-H., Hsieh, C., Lin, W., Wey, S., Kung, M., Yen, T., Lu, C., & Hsiao, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075952 · Cited by 35
Sadovski, O., Hicks, J. W., Parkes, J., Raymond, R., Nóbrega, J. N., Houle, S., Cipriano, M., Fowler, C. J., Vasdev, N., & Wilson, A. A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.077 · Cited by 35
Tang, J., Salloum, D., Carney, B. D., Brand, C., Kossatz, S., Sadique, A., Lewis, J. S., Weber, W., Wendel, H., & Reiner, T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705013114 · Cited by 35
Carlsen, E. A., Loft, M. D., Loft, A., Berthelsen, A. K., Langer, S. W., Knigge, U., & Kjær, A. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263177 · Cited by 35
Zhang, S., Ma, X., Jiang, W., Shen, J., Shi, Y., Wang, X., Xie, L., Sun, X., Wu, Y., Tian, H., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.07.006 · Cited by 35
Self-citationCarnevali, L., Vacondio, F., Rossi, S., Callegari, S., Macchi, E., Spadoni, G., Bedini, A., Rivara, S., Mor, M., & Sgoifo, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.07.015 · Cited by 34
Skaddan, M. B., Zhang, L., Johnson, D. S., Zhu, A., Zasadny, K. R., Coelho, R. V., Kuszpit, K. K., Currier, G., Fan, K., Beck, E. M., et al. (2012) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.03.011 · Cited by 34
Integration of organoids in peptide drug discovery: Rise of the high‐throughput screening
Zhang, S., Shen, J., Wang, X., Sun, X., Wu, Y., Zhang, M., Wang, R., & Hu, K. (2023) · View · doi:10.1002/viw.20230010 · Cited by 34
Self-citationRadiopharmaceuticals as combinatorial partners for immune checkpoint inhibitors
Pouget, J., Chan, T. A.-T., Galluzzi, L., & Constanzo, J. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.07.014 · Cited by 34
Burkett, B. J., Johnson, D. R., & Lowe, V. J. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266463 · Cited by 34
Radiolabeled Humanized Anti-CD3 Monoclonal Antibody Visilizumab for Imaging Human T-Lymphocytes
Malviya, G., D’Alessandria, C., Bonanno, E., Vexler, V. S., Massari, R., Trotta, C., Scopinaro, F., Dierckx, R. A. J. O., & Signore, A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.059485 · Cited by 33
Penninckx, S., Cekanaviciute, E., Degorre, C., Guiet, E., Viger, L., Lucasb, S., & Costes, S. V. (2019) · Radiation Research · doi:10.1667/rr15338.1 · Cited by 33
Whole-body PET Imaging of T-cell Response to Glioblastoma
Nobashi, T. W., Mayer, A. T., Xiao, Z., Chan, C. T., Chaney, A. M., James, M. L., & Gambhir, S. S. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-1412 · Cited by 33
Wang, S., Qi, C., Ding, J., Li, D., Zhang, M., Ji, C., Jiang, F., Teng, F., Yu, J., Qian, X., et al. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06234-z · Cited by 33
PET Tracers for Imaging Cardiac Function in Cardio-oncology
Kelly, J. M., & Babich, J. W. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01641-4 · Cited by 32
Delbart, W., Karabet, J., Marin, G., Penninckx, S., Derrien, J., Ghanem, G., Flamen, P., & Wimana, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012369 · Cited by 32
Xie, L., Zhang, L., Hu, K., Hanyu, M., Zhang, Y., Fujinaga, M., Minegishi, K., Ohkubo, T., Nagatsu, K., Jiang, C., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100960 · Cited by 32
Self-citationFreeby, M., Kringas, P., Goland, R., Leibel, R. L., Maffei, A., Divgi, C. R., Ichise, M., & Harris, P. E. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0888-7 · Cited by 31
Hindryckx, P., Staelens, S. G., Devisscher, L., Deleye, S., Vos, F. D., Delrue, L. J., Peeters, H., Laukens, D., & Vos, M. D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21578 · Cited by 31
Oi, N., Tokunaga, M., Suzuki, M., Nagai, Y., Nakatani, Y., Yamamoto, N., Maeda, J., Minamimoto, T., Zhang, M., Suhara, T., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00712 · Cited by 31
Kagitani‐Shimono, K., Kato, H., Kuwayama, R., Tominaga, K., Nabatame, S., Kishima, H., Hatazawa, J., & Taniike, M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02055-1 · Cited by 31
Liu, L., Zhong, J., Zhang, Z., Ye, X., Wang, X., Liu, S., & Zhang, Z. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06626-9 · Cited by 31
Self-citationPilot prospective evaluation of 18F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer
Minamimoto, R., Karam, A., Jamali, M., Barkhodari, A., Gambhir, S. S., Dorigo, O., & Iagaru, A. H. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3263-7 · Cited by 30
Solanki, J. H., Tritt, T., Pasternack, J. B., Kim, J. J., Leung, C. N., Domogauer, J., Colangelo, N. W., Narra, V. R., & Howell, R. W. (2017) · Radiation Research · doi:10.1667/rr14766.1 · Cited by 30
Evaluation of [18F]-N-Methyl lansoprazole as a Tau PET Imaging Agent in First-in-Human Studies
Kramer, V., Brooks, A. F., Haeger, A., Kuljiš, R. O., Rafique, W., Koeppe, R. A., Raffel, D. M., Frey, K. A., Horacio Amaral, P., Scott, P. J. H., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00639 · Cited by 29
Sun, X., Wu, Y., Wang, X., Gao, X., Zhang, S., Sun, Z., Liu, R., & Hu, K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030345 · Cited by 29
Self-citationBiokinetics and Dosimetry of [177Lu]Lu-Pentixather
Hänscheid, H., Schirbel, A., Hartrampf, P. E., Kraus, S., Werner, R. A., Einsele, H., Wester, H., Laßmann, M., Kortüm, K. M., & Buck, A. K. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262295 · Cited by 28
SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations
Voss, S. D. (2023) · Pediatric Radiology · doi:10.1007/s00247-023-05597-7 · Cited by 28
Xie, L., Hanyu, M., Fujinaga, M., Zhang, Y., Hu, K., Minegishi, K., Jiang, C., Kurosawa, F., Morokoshi, Y., Li, H. K., et al. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.230946 · Cited by 27
Self-citation64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma
Kang, L., Li, C., Yang, Q. E., Sutherlin, L. T., Wang, L., Chen, Z., Becker, K. V., Huo, N., Qiu, Y., Engle, J. W., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05593-9 · Cited by 27
Self-citationGallus, M., Roll, W., Dik, A., Barca, C., Zinnhardt, B., Hicking, G., Mueller, C., Naik, V. N., Anstötz, M., Krämer, J., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq7595 · Cited by 27
Tauber, C., Beaufils, É., Hommet, C., Ribeiro, M. J., Vercouillie, J., Vierron, E., Mondon, K., Cottier, J., Gissot, V., Guilloteau, D., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122068 · Cited by 26
Naganawa, M., Lim, K., Nabulsi, N., Lin, S.-F., Labaree, D. C., Ropchan, J. R., Herold, K. C., Huang, Y. H., Harris, P. E., Ichise, M., et al. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1170-6 · Cited by 26
Kruk-Słomka, M., Banaszkiewicz, I., Słomka, T., & Biała, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1596-0 · Cited by 26
Rong, J., Mori, W., Xia, X., Schafroth, M. A., Zhao, C., Van, R. S., Yamasaki, T., Chen, J., Xiao, Z., Haider, A., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00747 · Cited by 26
Self-citationHandula, M., Beekman, S., Konijnenberg, M., Stuurman, D. C., de Ridder, C., Bruchertseifer, F., Morgenstern, A., Denkova, A. G., de Blois, E., & Seimbille, Y. (2023) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-023-00197-0 · Cited by 26
Köller, L., Joksch, M., Schwarzenböck, S. M., Kurth, J., Heuschkel, M., Holzleitner, N., Beck, R., Amsberg, G. V., Wester, H., Krause, B. J., et al. (2023) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.265771 · Cited by 26
Use of 99mTc-anti-CD3 scintigraphy in the differential diagnosis of rheumatic diseases
Lopes, F. P. P. L., de Azevedo, M. N. L., Marchiori, E. D. S., da Fonseca, L. M. B., de Souza, S. A. L., & Gutfilen, B. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/kep471 · Cited by 25
A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors
Takahata, K., Kimura, Y., Seki, C., Tokunaga, M., Ichise, M., Kawamura, K., Ono, M., Kitamura, S., Kubota, M., Moriguchi, S., et al. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0313-0 · Cited by 25
Dietz, M., Kamani, C. H., Deshayes, E., Dunet, V., Mitsakis, P., Coukos, G., Lalonde, M. N., Schaefer, N. G., & Prior, J. O. (2021) · EJNMMI Research · doi:10.1186/s13550-021-00815-5 · Cited by 25
[11C]K-2 image with positron emission tomography represents cell surface AMPA receptors
Arisawa, T., Miyazaki, T., Ota, W., Sano, A., Suyama, K., Takada, Y., & Takahashi, T. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.05.009 · Cited by 25
Liu, H., Hu, M. L., Deng, J., Zhao, Y., Peng, D., Feng, Y., Wang, L., Chen, Y., & Qiu, L. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00694 · Cited by 25
Ra-223 induces clustered DNA damage and inhibits cell survival in several prostate cancer cell lines
Abramenkovs, A., Hariri, M., Spiegelberg, D., Nilsson, S. F., & Stenerlöw, B. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101543 · Cited by 25
Cheval, M., Rodrigo, S., Taussig, D., Caillé, F., Petrescu, A. M., Bottlaender, M., Tournier, N., Besson, F. L., Leroy, C., & Bouilleret, V. (2023) · Neurology · doi:10.1212/wnl.0000000000207811 · Cited by 24
Alpha‐Emitter Radium‐223 Induces STING‐Dependent Pyroptosis to Trigger Robust Antitumor Immunity
Yang, M., Liu, H., Lou, J., Zhang, J., Zuo, C., Zhu, M., Zhang, X., Yin, Y., Zhang, Y., Qin, S., et al. (2023) · Small · doi:10.1002/smll.202307448 · Cited by 24
Liu, M., Cheng, Y., Bai, C., Zhao, H., Jia, R., Chen, J., Zhu, W., & Huo, L. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06639-4 · Cited by 24
Kang, C. M., Kim, S. M., Koo, H., Yim, M. S., Lee, K.-H., Ryu, E. K., & Choe, Y. S. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2266-x · Cited by 23
Bienert, M., Reisinger, I., Srock, S., Humplik, B. I., Reim, C., Krössin, T., Avril, N. E., Pezzutto, A., & Munz, D. L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1770-7 · Cited by 23
Yamasaki, T., Mori, W., Zhang, Y., Hatori, A., Fujinaga, M., Wakizaka, H., Kurihara, Y., Wang, L., Nengaki, N., Ohya, T., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.05.015 · Cited by 23
Metadata
- Authors
- Zhang, S., Wang, X., Gao, X., Chen, X., Li, L., Li, G., Liu, C., Miao, Y., Wang, R., & Hu, K.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2025-01-03
- Volume
- 10
- Issue
- 1
- Pages
- 1-1
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4406003699
- Cited by
- 284
- References
- 454
- FWCI
- 151.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.